A Single Dose, Cytomegalovirus-based Vaccine to Induce Heterosubtypic Protective Immunity to Influenza A Virus

Project Information

MAJARVISCIG

Grant agreement ID: 334487

Project closed

Start date 1 July 2013

End date 31 August 2017

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

UNIVERSITY OF PLYMOUTH
United Kingdom